101
Views
82
CrossRef citations to date
0
Altmetric
Research Article

Butyrylcholinesterase activity and risk factors for coronary artery disease

, , , , &
Pages 399-404 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Xiaoli Zhu & Jinxi Hu. (2022) Cholinesterase is a Potential Biomarker with High Accuracy for the Nephrotic Syndrome Diagnosis in Minors. Journal of Multidisciplinary Healthcare 15, pages 2375-2383.
Read now
Carla da Silva Benetti, Patrícia Pelufo Silveira, Angela T. S. Wyse, Emilene B. S. Scherer, Andréa G. K. Ferreira, Carla Dalmaz & Marcelo Zubaran Goldani. (2014) Neonatal environmental intervention alters the vulnerability to the metabolic effects of chronic palatable diet exposure in adulthood. Nutritional Neuroscience 17:3, pages 127-137.
Read now
A. Vaisi‐Raygani, Z. Rahimi, H. Entezami, H. Kharrazi, F. Bahrhemand, H. Tavilani, M. Rezaei, A. Kiani, B. Nomanpour & T. Pourmotabbed. (2008) Butyrylcholinesterase K variants increase the risk of coronary artery disease in the population of western Iran. Scandinavian Journal of Clinical and Laboratory Investigation 68:2, pages 123-129.
Read now
Annie H. Shinn, Sian M. Carr-Lopez, James W. Smith, Elizabeth A. Elledge & Timothy J. Smith. (2005) Effects of switching pravastatin to cerivastatin on C-reactive protein, butyrylcholinesterase, and lipids. Current Medical Research and Opinion 21:2, pages 207-213.
Read now

Articles from other publishers (77)

Megan Wilson, Abdullah Al‐Hamid, Ismail Abbas, Jason Birkett, Iftikhar Khan, Matthew Harper, Dhiya Al‐Jumeily OBE & Sulaf Assi. (2024) Identification of diagnostic biomarkers used in the diagnosis of cardiovascular diseases and diabetes mellitus: A systematic review of quantitative studies. Diabetes, Obesity and Metabolism.
Crossref
Muslum Gok, Cigdem Cicek & Ebru Bodur. (2023) Butyrylcholinesterase in lipid metabolism: A new outlook. Journal of Neurochemistry 168:4, pages 381-385.
Crossref
Yousaf Khan, Shoaib Khan, Rafaqat Hussain, Wajid Rehman, Aneela Maalik, Urooba Gulshan, Mohamed W. Attwa, Hany W. Darwish, Hazem A. Ghabbour & Nawab Ali. (2023) Identification of Indazole-Based Thiadiazole-Bearing Thiazolidinone Hybrid Derivatives: Theoretical and Computational Approaches to Develop Promising Anti-Alzheimer’s Candidates. Pharmaceuticals 16:12, pages 1667.
Crossref
Wenjing Xue, Yi Wei & Yuanhui Hu. (2023) Association between serum cholinesterase and the prevalence of atrial fibrillation in Chinese hypertensive population: a cross-sectional study. European Journal of Medical Research 28:1.
Crossref
Wei Yuan, Chenyang Wan, Jingjing Zhang, Qisheng Li, Peng Zhang, Ke Zheng, Qian Zhang & Caifeng Ding. (2023) Near-infrared ratiometric fluorescent strategy for butyrylcholinesterase activity and its application in the detection of pesticide residue in food samples and biological imaging. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 297, pages 122719.
Crossref
Alperen Acari, Toghrul Almammadov, Musa Dirak, Goktug Gulsoy & Safacan Kolemen. (2023) Real-time visualization of butyrylcholinesterase activity using a highly selective and sensitive chemiluminescent probe. Journal of Materials Chemistry B 11:29, pages 6881-6888.
Crossref
Hayat Ullah, Mehvish Jabeen, Fazal Rahim, Amjad Hussain, Fahad Khan, Muhammad Perviaz, Muhammad Sajid, Imad Uddin, Muhammad Usman Khan & Muhammad Nabi. (2023) Synthesis, acetylcholinesterase and butyrylcholinesterase inhibitory potential and molecular docking study of thiazole bearing thiourea analogues. Chemical Data Collections 44, pages 100988.
Crossref
Muhammad Taha, Fazal Rahim, Nizam Uddin, Ihsan Ullah Khan, Naveed Iqbal, El Hassane Anouar, Mohammed Salahuddin, Rai Khalid Farooq, Mohammed Gollapalli, Khalid Mohammed Khan & Ameeduzzafar Zafar. (2021) Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors. International Journal of Biological Macromolecules 188, pages 1025-1036.
Crossref
Pratibha Magar, Oscar Parravicini, Šárka Štěpánková, Katarina Svrčková, Adriana D. Garro, Izabela Jendrzejewska, Karel Pauk, Jan Hošek, Josef Jampílek, Ricardo D. Enriz & Aleš Imramovský. (2021) Novel Sulfonamide-Based Carbamates as Selective Inhibitors of BChE. International Journal of Molecular Sciences 22:17, pages 9447.
Crossref
Christian Gentzsch, Matthias Hoffmann, Yasuhiro Ohshima, Naoko Nose, Xinyu Chen, Takahiro Higuchi & Michael Decker. (2021) Synthesis and Initial Characterization of a Selective, Pseudo‐irreversible Inhibitor of Human Butyrylcholinesterase as PET Tracer. ChemMedChem 16:9, pages 1427-1437.
Crossref
Odunayo Michael Agunloye & Ganiyu Oboh. (2021) High cholesterol diet promotes dysfunction of arginase and cholinergic enzymatic system in rats: ameliorative role of caffeic and chlorogenic acids. Journal of Complementary and Integrative Medicine 18:1, pages 67-74.
Crossref
Ilya N. Kurochkin, Arkadiy V. Eremenko, Evgeniy G. Evtushenko, Natalia L. Nechaeva, Nikolay N. Durmanov, Rustam R. Guliev, Ilya A. Ryzhikov, Irina A. Boginskaya, Andrey K. Sarychev, A. V. Ivanov & Andrey N. Lagarkov. 2021. Macro, Micro, and Nano-Biosensors. Macro, Micro, and Nano-Biosensors 75 94 .
Williamjeet Sidhu, Lovleen Bhatia & Kanchan Vohra. (2020) Serum Cholinesterase Level as a Marker of Systemic Low-Grade Inflammation in Isolated Systolic Hypertension: A Cross-Sectional Study. European Journal of Medical and Health Sciences 2:6.
Crossref
Nunzio Pomara & Bruno P. Imbimbo. (2020) Impairment of the cholinergic anti-inflammatory pathway in older subjects with severe COVID-19. Medical Hypotheses 144, pages 110274.
Crossref
Iris Betzaida Molina-Pintor, Aurora Elizabeth Rojas-García, Yael Yvette Bernal-Hernández, Irma Martha Medina-Díaz, Cyndia Azucena González-Arias & Briscia Socorro Barrón-Vivanco. (2020) Relationship between butyrylcholinesterase activity and lipid parameters in workers occupationally exposed to pesticides. Environmental Science and Pollution Research 27:31, pages 39365-39374.
Crossref
Chuanhai Wu, Yan-bei Tu, Ziyuan Li & Yan-fang Li. (2019) Highly selective carbamate-based butyrylcholinesterase inhibitors derived from a naturally occurring pyranoisoflavone. Bioorganic Chemistry 88, pages 102949.
Crossref
Takoua Ben Issa, Fayçal Sayari, Houcine Ghalla & Latifa Benhamada. (2019) Synthesis, crystal structure, DFT calculations and molecular docking of l-pyroglutamic acid. Journal of Molecular Structure 1178, pages 436-449.
Crossref
Hemantha Kumara DS & Gurupadappa K. (2018) Correlation of Serum Cholinesterase with Lipid Indices in Type 2 Diabetes Mellitus Patients in McGann Teaching Hospital, Shimoga, Karnataka, India. Indian journal of Medical Biochemistry 22:2, pages 154-156.
Crossref
Natalia Nechaeva, Taisiya Prokopkina, Galina Makhaeva, Elena Rudakova, Natalia Boltneva, Christophor Dishovsky, Arkadiy Eremenko & Ilya Kurochkin. (2018) Quantitative butyrylcholinesterase activity detection by surface-enhanced Raman spectroscopy. Sensors and Actuators B: Chemical 259, pages 75-82.
Crossref
Piotr Duchnowicz, Anna Ziobro, Elżbieta Rapacka, Maria Koter-Michalak & Bożena Bukowska. (2018) Changes in Cholinesterase Activity in Blood of Adolescent with Metabolic Syndrome after Supplementation with Extract from Aronia melanocarpa . BioMed Research International 2018, pages 1-8.
Crossref
Jéssica de Oliveira, Luciane Viater Tureck, Willian dos Santos, Louise Farah Saliba, Caroline Schovanz Schenknecht, Débora Scaraboto, Ricardo Lehtonen R. Souza & Lupe Furtado-Alle. (2017) Effect of BCHE single nucleotide polymorphisms on lipid metabolism markers in women. Genetics and Molecular Biology 40:2, pages 408-414.
Crossref
Edyta Pytel, Bożena Bukowska, Maria Koter-Michalak, Małgorzata Olszewska-Banaszczyk, Paulina Gorzelak-Pabiś & Marlena Broncel. (2017) Effect of intensive lipid-lowering therapies on cholinesterase activity in patients with coronary artery disease. Pharmacological Reports 69:1, pages 150-155.
Crossref
Vicky Ping Chen, Yang Gao, Liyi Geng, Michael B. Stout, Michael D. Jensen & Stephen Brimijoin. (2016) Butyrylcholinesterase Deficiency Promotes Adipose Tissue Growth and Hepatic Lipid Accumulation in Male Mice on High-Fat Diet. Endocrinology 157:8, pages 3086-3095.
Crossref
Edgar Sawatzky, Ehab Al‐Momani, Ryohei Kobayashi, Takahiro Higuchi, Samuel Samnick & Michael Decker. (2016) A Novel Way To Radiolabel Human Butyrylcholinesterase for Positron Emission Tomography through Irreversible Transfer of the Radiolabeled Moiety. ChemMedChem 11:14, pages 1540-1550.
Crossref
Ramazan Kocabaş, Ali Kemal Erenler, Mücahit Yetim, Tolga Doğan & Hacı Kemal Erdemli. (2016) Butyrylcholinesterase as an additional marker in the diagnostic network of acute myocardial infarction. LaboratoriumsMedizin 40:2, pages 147-152.
Crossref
Edgar Sawatzky, Sarah Wehle, Beata Kling, Jan Wendrich, Gerhard Bringmann, Christoph A. Sotriffer, Jörg Heilmann & Michael Decker. (2016) Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode. Journal of Medicinal Chemistry 59:5, pages 2067-2082.
Crossref
K. ŠIŠKOVÁ, M. DUBNIČKOVÁ, Ľ. PAŠKOVÁ, D. RAJDL, Z. ĎURAČKOVÁ, J. MUCHOVÁ, I. PAULIKOVÁ & J. RACEK. (2016) Betaine Increases the Butyrylcholinesterase Activity in Rat Plasma. Physiological Research, pages 101-108.
Crossref
Nir Waiskopf, Shani Shenhar-Tsarfaty & Hermona Soreq. 2016. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease 197 218 .
Joanna Jo?ca, Monika ?uk, Bartosz Was?g, Anna Janaszak-Jasiecka, Krzysztof Lewandowski, Bartosz Wielgomas, Krzysztof Waleron & Jacek Jasiecki. (2015) New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial Parameter. PLOS ONE 10:10, pages e0139480.
Crossref
Surapon Tangvarasittichai, Suthap Pongthaisong, Suwadee Meemark & Orathai Tangvarasittichai. (2014) Abdominal Obesity Associated with Elevated Serum Butyrylcholinesterase Activity, Insulin Resistance and Reduced High Density Lipoprotein-Cholesterol Levels. Indian Journal of Clinical Biochemistry 30:3, pages 275-280.
Crossref
Patrick Sulzgruber, Lorenz Koller, Thomas Reiberger, Feras El-Hamid, Stefan Forster, David-Jonas Rothgerber, Georg Goliasch, Johann Wojta & Alexander Niessner. (2015) Butyrylcholinesterase Predicts Cardiac Mortality in Young Patients with Acute Coronary Syndrome. PLOS ONE 10:5, pages e0123948.
Crossref
Nir Waiskopf, Shani Shenhar-Tsarfaty & Hermona Soreq. 2015. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease 1 22 .
Dominika Dingova, Jacqueline Leroy, Abel Check, Vladimir Garaj, Eric Krejci & Anna Hrabovska. (2014) Optimal detection of cholinesterase activity in biological samples: Modifications to the standard Ellman’s assay. Analytical Biochemistry 462, pages 67-75.
Crossref
Emilene B. S. Scherer, Samanta O. Loureiro, Fernanda C. Vuaden, Aline A. da Cunha, Felipe Schmitz, Janaína Kolling, Luiz Eduardo B. Savio, Maurício R. Bogo, Carla D. Bonan, Carlos A. Netto & Angela T. S. Wyse. (2014) Mild Hyperhomocysteinemia Increases Brain Acetylcholinesterase and Proinflammatory Cytokine Levels in Different Tissues. Molecular Neurobiology 50:2, pages 589-596.
Crossref
Shani Shenhar-Tsarfaty, Shlomo Berliner, Natan M. Bornstein & Hermona Soreq. (2013) Cholinesterases as Biomarkers for Parasympathetic Dysfunction and Inflammation-Related Disease. Journal of Molecular Neuroscience 53:3, pages 298-305.
Crossref
A. M. Cardoso, F. H. Abdalla, M. D. Bagatini, C. C. Martins, F. da Silva Fiorin, J. Baldissarelli, P. Costa, F. F. de Mello, A. M. Fiorenza, J. D. da Silva Serres, J. F. Goncalves, H. Chaves, L. F. F. Royes, A. Bello-Klein, V. M. Morsch & M. R. C. Schetinger. (2013) Swimming Training Prevents Alterations in Acetylcholinesterase and Butyrylcholinesterase Activities in Hypertensive Rats. American Journal of Hypertension 27:4, pages 522-529.
Crossref
Kyoko Kogawa Sato, Tomoshige Hayashi, Isseki Maeda, Hideo Koh, Nobuko Harita, Shinichiro Uehara, Yukiko Onishi, Keiko Oue, Yoshiko Nakamura, Ginji Endo, Hiroshi Kambe & Kanji Fukuda. (2013) Serum butyrylcholinesterase and the risk of future type 2 diabetes: the Kansai Healthcare Study. Clinical Endocrinology 80:3, pages 362-367.
Crossref
Larissa O. Guimarães, Fabiana A. de Andrade, Gleyse F. Bono, Thaís E. Setoguchi, Mariana B. Brandão, Eleidi A. Chautard-Freire-Maia, Izabella C.R. dos Santos, Geraldo Picheth, Ana Cristina R. de A. Faria, Rosângela R. Réa, Ricardo L.R. Souza & Lupe Furtado-Alle. (2014) Gestational diabetes mellitus (GDM) decreases butyrylcholinesterase (BChE) activity and changes its relationship with lipids. Genetics and Molecular Biology 37:1, pages 1-6.
Crossref
Danusa Mar Arcego, Rachel Krolow, Carine Lampert, Cristie Noschang, Andréa G.K. Ferreira, Emilene Scherer, Angela T.S. Wyse & Carla Dalmaz. (2014) Isolation during the prepubertal period associated with chronic access to palatable diets: Effects on plasma lipid profile and liver oxidative stress. Physiology & Behavior 124, pages 23-32.
Crossref
Karine S. De Bona, Gabriela Bonfanti, Paula E. R. Bitencourt, Lariane O. Cargnelutti, Priscila S. da Silva, Leidiane De Lucca, Victor C. Pimentel, Etiane Tatsch, Thissiane L. Gonçalves, Melissa Premaor, Rafael N. Moresco & Maria Beatriz Moretto. (2013) Butyrylcholinesterase and γ-Glutamyltransferase Activities and Oxidative Stress Markers Are Altered in Metabolic Syndrome, But Are Not Affected by Body Mass Index. Inflammation 36:6, pages 1539-1547.
Crossref
Tanja Antunovic, Aleksandra Stefanovic, Marina Ratkovic, Branka Gledovic, Najdana Gligorovic-Barhanovic, Dragica Bozovic, Jasmina Ivanisevic, Milica Prostran & Marina Stojanov. (2012) High uric acid and low superoxide dismutase as possible predictors of all-cause and cardiovascular mortality in hemodialysis patients. International Urology and Nephrology 45:4, pages 1111-1119.
Crossref
Sarunya Thiphom, Tippawan Prapamontol, Somporn Chantara, Ampica Mangklabruks & Chaisuree Suphavilai. (2013) A method for measuring cholinesterase activity in human saliva and its application to farmers and consumers. Analytical Methods 5:18, pages 4687.
Crossref
Glynis Johnson & Samuel W. Moore. (2012) Why has butyrylcholinesterase been retained? Structural and functional diversification in a duplicated gene. Neurochemistry International 61:5, pages 783-797.
Crossref
Georg Goliasch, Arvand Haschemi, Rodrig Marculescu, Georg Endler, Gerald Maurer, Oswald Wagner, Kurt Huber, Christine Mannhalter & Alexander Niessner. (2012) Butyrylcholinesterase Activity Predicts Long-Term Survival in Patients with Coronary Artery Disease. Clinical Chemistry 58:6, pages 1055-1058.
Crossref
A. Tvarijonaviciute, J.J. Ceron & M. Caldin. (2012) Serum butyrylcholinesterase activity in dogs with diabetes mellitus. The Veterinary Journal 192:3, pages 494-497.
Crossref
Undurti N Das. (2012) Acetylcholinesterase and butyrylcholinesterase as markers of low-grade systemic inflammation. Annals of Hepatology 11:3, pages 409-411.
Crossref
Felipe Schmitz, Emilene Barros da Silva Scherer, Maira Jaqueline da Cunha, Aline Andrea da Cunha, Daniela Delwing Lima, Débora Delwing, Carlos Alexandre Netto & Angela Terezinha de Souza Wyse. (2011) Chronic methylphenidate administration alters antioxidant defenses and butyrylcholinesterase activity in blood of juvenile rats. Molecular and Cellular Biochemistry 361:1-2, pages 281-288.
Crossref
Taher Darreh-Shori, Anton Forsberg, Negar Modiri, Niels Andreasen, Kaj Blennow, Chelenk Kamil, Hiba Ahmed, Ove Almkvist, Bengt Långström & Agneta Nordberg. (2011) Differential levels of apolipoprotein E and butyrylcholinesterase show strong association with pathological signs of Alzheimer's disease in the brain in vivo. Neurobiology of Aging 32:12, pages 2320.e15-2320.e32.
Crossref
Jaideep J. Pandit, Satish Gopa & Jason Arora. (2011) A hypothesis to explain the high prevalence of pseudo-cholinesterase deficiency in specific population groups. European Journal of Anaesthesiology 28:8, pages 550-552.
Crossref
Marina Stojanov, Aleksandra Stefanović, Gordana Džingalašević, Slavka Mandić-Radić & Milica Prostran. (2011) Butyrylcholinesterase activity in young men and women: Association with cardiovascular risk factors. Clinical Biochemistry 44:8-9, pages 623-626.
Crossref
Matthew Blatnik & Catherine I. Soderstrom. (2011) A practical guide for the stabilization of acylghrelin in human blood collections. Clinical Endocrinology 74:3, pages 325-331.
Crossref
Daniela Delwing‐de Lima, Luiz Felipe Wollinger, Ana Carolina Mesquita Casagrande, Fábio Delwing, José Geraldo Pereira da Cruz, Angela T.S. Wyse & Débora Delwing‐Dal Magro. (2010) Guanidino compounds inhibit acetylcholinesterase and butyrylcholinesterase activities: Effect neuroprotector of vitamins E plus C. International Journal of Developmental Neuroscience 28:6, pages 465-473.
Crossref
Bárbara Tagliari, Tiago M. dos Santos, Aline A. Cunha, Daniela D. Lima, Débora Delwing, Angela Sitta, Carmem R. Vargas, Carla Dalmaz & Angela T. S. Wyse. (2010) Chronic variable stress induces oxidative stress and decreases butyrylcholinesterase activity in blood of rats. Journal of Neural Transmission 117:9, pages 1067-1076.
Crossref
Gracielle Alves-Amaral, Marcelo Pires-Oliveira, Ana Luiza Andrade-Lopes, Tiago Chiavegatti & Rosely Oliveira Godinho. (2010) Gender-related differences in circadian rhythm of rat plasma acetyl- and butyrylcholinesterase: Effects of sex hormone withdrawal. Chemico-Biological Interactions 186:1, pages 9-15.
Crossref
Mauro M. Cwiertnia, Vânia M. Alcântara, Rosângela R. Réa, Ana Cristina R. A. Faria, Geraldo Picheth, Marileia Scartezini, Lorena E. Graef & Marciane Welter. (2010) Butyrylcholinesterase and diabetes mellitus in the CHE2 C5- and CHE2 C5+ phenotypes. Arquivos Brasileiros de Endocrinologia & Metabologia 54:1, pages 60-67.
Crossref
James W Albers, David H Garabrant, Stanley Berent & Rudy J Richardson. (2009) Paraoxonase status and plasma butyrylcholinesterase activity in chlorpyrifos manufacturing workers. Journal of Exposure Science & Environmental Epidemiology 20:1, pages 79-89.
Crossref
Marina D. Stojanov, Du?anka M. Jovi?i?Stevan P. Djuri?Marija M. Konjevi?Zoran M. Todorovi?Milica ?. Prostran. (2009) Butyrylcholinesterase activity and mortality risk in hemodialysis patients: Comparison to hsCRP and albumin. Clinical Biochemistry 42:1-2, pages 22-26.
Crossref
Maria Stasiuk, Dominika Bartosiewicz & Arkadiusz Kozubek. (2008) Inhibitory effect of some natural and semisynthetic phenolic lipids upon acetylcholinesterase activity. Food Chemistry 108:3, pages 996-1001.
Crossref
Solange C. Garcia, ?ngela T.S. Wyse, Juliana Valentini, Miguel Roehrs, Angela M. Moro, Cl?vis Paniz, Gabriela Schmitt, Denise Grotto & Valdeci J. Pomblum. (2008) Butyrylcholinesterase activity is reduced in haemodialysis patients: Is there association with hyperhomocysteinemia and/or oxidative stress?. Clinical Biochemistry 41:7-8, pages 474-479.
Crossref
Siomara C. Monteiro, Cristiane B. Mattos, Emilene B. S. Scherer & Angela T. S. Wyse. (2007) Supplementation with vitamins E plus C or soy isoflavones in ovariectomized rats: effect on the activities of Na+, K+-ATPase and cholinesterases. Metabolic Brain Disease 22:2, pages 156-171.
Crossref
Emilene B.S. Scherer, Francieli M. Stefanello, Cristiane Mattos, Carlos Alexandre Netto & Angela T.S. Wyse. (2007) Homocysteine reduces cholinesterase activity in rat and human serum. International Journal of Developmental Neuroscience 25:4, pages 201-205.
Crossref
T. Zelinski, G. Coghlan, J. Mauthe & B. Triggs-Raine. (2007) Molecular basis of succinylcholine sensitivity in a prairie Hutterite kindred and genetic characterization of the region containing the BCHE gene. Molecular Genetics and Metabolism 90:2, pages 210-216.
Crossref
Allam A. Rao, Gumpeny R. Sridhar & Undurti N. Das. (2007) Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer?s disease. Medical Hypotheses 69:6, pages 1272-1276.
Crossref
Bożena Bukowska & Katarzyna Hutnik. (2006) 2,4-D and MCPA and their derivatives: Effect on the activity of membrane erythrocytes acetylcholinesterase (in vitro). Pesticide Biochemistry and Physiology 85:3, pages 174-180.
Crossref
Ronit Calderon-Margalit, Bella Adler, Joseph H Abramson, Jaime Gofin & Jeremy D Kark. (2006) Butyrylcholinesterase Activity, Cardiovascular Risk Factors, and Mortality in Middle-Aged and Elderly Men and Women in Jerusalem. Clinical Chemistry 52:5, pages 845-852.
Crossref
Gilberto In?cio Lunkes, Franciele Stefanello, Dani?le Sausen Lunkes, Vera Maria Morsch, Maria Rosa Chitolina Schetinger & Jamile Fabbrin Gon?alves. (2006) Serum cholinesterase activity in diabetes and associated pathologies. Diabetes Research and Clinical Practice 72:1, pages 28-32.
Crossref
Bassam A. Nassar, Kenneth Rockwood, Susan A. Kirkland, Thomas P. Ransom, Sultan Darvesh, Kathleen MacPherson, David E. Johnstone, Blair J. O'Neill, Iqbal R. Bata, Pantelis Andreou, Julie S. Jeffery, Jafna L. Cox & Lawrence M. Title. (2006) Improved prediction of early-onset coronary artery disease using APOE ?4, BChE-K, PPAR?2 Pro12 and ENOS T-786C in a polygenic model. Clinical Biochemistry 39:2, pages 109-114.
Crossref
Peter Gre?ner, Martin Doln?k, Iveta Waczul?kov?Maria Bryszewska, Libu?a ?ikurov?Cezary Watala. (2006) Increased blood plasma hydrolysis of acetylsalicylic acid in type 2 diabetic patients: A role of plasma esterases. Biochimica et Biophysica Acta (BBA) - General Subjects 1760:2, pages 207-215.
Crossref
Elsa Reiner & Vera Simeon-Rudolf. 2006. Toxicology of Organophosphate & Carbamate Compounds. Toxicology of Organophosphate & Carbamate Compounds 199 208 .
GR Sridhar, G Nirmala, Allam Apparao, AS Madhavi, S Sreelatha, J Sudha Rani & P Vijayalakshmi. (2005) Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach. Lipids in Health and Disease 4:1.
Crossref
Bin Li, Meghan Sedlacek, Indumathi Manoharan, Rathnam Boopathy, Ellen G. Duysen, Patrick Masson & Oksana Lockridge. (2005) Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochemical Pharmacology 70:11, pages 1673-1684.
Crossref
Edward W. Randell, Maria S. Mathews, Hongwei Zhang, Jim S. Seraj & Guang Sun. (2005) Relationship between serum butyrylcholinesterase and the metabolic syndrome. Clinical Biochemistry 38:9, pages 799-805.
Crossref
Francieli M. Stefanello, Renata Franzon, Bárbara Tagliari, Clovis M. D. Wannmacher, Moacir Wajner & Angela T. S. Wyse. (2005) Reduction of Butyrylcholinesterase Activity in Rat Serum Subjected to Hyperhomocysteinemia. Metabolic Brain Disease 20:2, pages 97-103.
Crossref
Vânia M. Alcântara, Lisangela C. Oliveira, Rosângela R. Réa, Henrique L. Suplicy & Eleidi A. Chautard-Freire-Maia. (2005) Butyrylcholinesterase activity and metabolic syndrome in obese patients. Clinical Chemistry and Laboratory Medicine (CCLM) 43:3.
Crossref
János Kálmán, Anna Juhász, Zoltán Rakonczay, György Ábrahám, Marianna Zana, Krisztina Boda, Tibor Farkas, Botond Penke & Zoltán Janka. (2004) Increased serum butyrylcholinesterase activity in type IIb hyperlipidaemic patients. Life Sciences 75:10, pages 1195-1204.
Crossref
J?nos K?lm?n, Anna Juh?sz, Zolt?n Rakonczay, Gy?rgy ?brah?m, Krisztina Boda, Tibor Farkas, Botond Penke & Zolt?n Janka. (2004) Serum butyrylcholinesterase activity in hyperlipidaemia. Atherosclerosis 173:1, pages 145-146.
Crossref
V M Alcântara, L C Oliveira, R R Réa, H L Suplicy & E A Chautard-Freire-Maia. (2003) Butyrylcholinesterase and obesity in individuals with the CHE2 C5+ and CHE2 C5− phenotypes. International Journal of Obesity 27:12, pages 1557-1564.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.